You are here

Featured Stories

Featured Stories

Featured Stories

Across the globe, with the increase in online pharmacies and improved manufacturing technology, knockoff drugs are proliferating. Nearly every type of drug is susceptible to counterfeiting¬— from anti-malarial drugs and antibiotics to cholesterol and anti-inflammatory medicines. Often available at discount prices and without a prescription, these drugs pose a serious public health risk: some are less-potent version of the original formula; others contain toxic ingredients.

This microdocumentary shares the moving story of a family with two young sons who have severe hemophilia, giving us a glimpse into their history and treatment routine. Hemophilia is a rare bleeding disorder in which the body is unable to properly create a blood clot. Beyond external bleeding, like a cut, people with hemophilia also bleed internally and in their joints, which can lead to crippling arthritis later in life.

How do parasites evade detection by the immune system? Why does a mutation in a mouse gene lead to the development of an autoimmune disease similar to human lupus? What kind of tag-team signals have to fire in sync for the body’s immune responses to be unleashed?

At Pfizer, our purpose is to make innovative medicines and vaccines that significantly improve people’s lives. In doing so, we are helping society achieve the United Nations Sustainable Development Goals (SDGs) – 17 ambitious targets for positive and essential change around the world.

On November 15, 2016, the World Health Organization (WHO) validated that the Moroccan government has eliminated trachoma as a public health problem, making it the second country in the world to achieve this designation after Oman in 2012.

Our donation of an antibiotic used to treat trachoma, in partnership with the International Trachoma Initiative (ITI), as well as the implementation of the WHO-recommend SAFE strategy, played pivotal roles in Morocco reaching this milestone, but there is more work to be done around the world.

The Avon-Pfizer Metastatic Grants Program was founded in 2014 to address unmet needs in this community. In its inaugural year, 23 grants totaling one million dollars were awarded to non-profits around the country to help navigate the unique medical and emotional challenges associated with metastatic cancer.

Pfizer’s metastatic breast cancer medicine has been named the “Best Pharmaceutical Product” at the 10th Annual Prix Galien USA Awards in New York, among the industry’s most prestigious accolades.

Prix Galien USA recognizes exceptional pharmaceutical innovations that have improved health around the globe. Pfizer’s metastatic breast cancer medicine took the top prize among a category of 22 products.

Duchenne muscular dystrophy (DMD) is a rare genetic disease that affects boys almost exclusively and causes progressive weakness.1 With symptom onset typically in early childhood, DMD can be a devastating diagnosis, with few disease-modifying treatment options available.1

The Zika epidemic is a growing and evolving global health emergency that has already spread to more than 45 countries, including U.S. territories and the continental U.S.1 Healthcare professionals are working rapidly to identify solutions for those impacted, and while the Centers for Disease Control and Prevention (CDC) is tracking the virus, it is not able to predict how much Zika will spread in the continental U.S.

We live in a Golden Age of health innovation. New pharmaceuticals are prolonging and saving lives. For example, two-thirds of patients diagnosed with cancer are alive at least five years after their diagnosis. [PhRMA] And the cost of drugs is often much lower than the cost of other treatments that would be needed if the drugs did not exist. In terms of overall healthcare spending, pharmaceuticals accounted for just 12% of total spending as of 2014 – this is the SAME as it was in 1960

When you think of a startup founder, the first image that comes to mind may be of a millennial in a hooded sweatshirt, pulling all-nighters to write software code.

But in fact, baby boomers (born between 1946 and 1964) are twice as likely as millennials to start new businesses, according to a 2015 Gallup poll1. Increasingly forgoing retirement for a second or third act, boomer entrepreneurs are putting their resources and lifetimes of experience to work to propel business ideas to success.

Freda Lewis-Hall, MD, Pfizer’s Chief Medical Officer and Executive Vice President, has been a member of Save the Children’s Board of Trustees since 2012. She shares Save the Children’s dedication to creating immediate and lasting change in the lives of children and families around the world.

Enhancing Care and Support for Patients Living with Metastatic Breast Cancer

Pfizer Oncology today announced the launch of a technology innovation challenge – Advancing Care for Patients Living with mBC – a first-of-its-kind initiative designed to find new technology-enabled solutions that help support and empower patients with metastatic breast cancer (mBC) around the world. A total of $250,000 in prize funding will be awarded for technology-enabled solutions with the greatest potential to enrich the lives of patients with mBC.

For Dr. Bill Gruber, seeing Saturn’s rings was the spark that ignited a lifelong passion for science.

“That was a pivotal moment – I realized this is something I really like to do. I was around five years old when my family took me to a local church yard to see Saturn through a telescope. I still get excited like I did when I was a young boy to discover something new, with the added value now of knowing that our new discoveries of vaccines have the potential to improve health for children and adults throughout the world.”

In an unprecedented collaboration, today, Pfizer and 13 industry partners released a comprehensive plan of action that lays out four key commitments we pledge to deliver by 2020 to reduce the rising incidence of antimicrobial resistance.

It was 1977 when Craig Lipset discovered that he was color-blind. “I was at a routine screening at my elementary school and I remember several other students waiting in the office at that time – one even whispered ‘I’m glad I’m not color-blind!’ I know it’s strange that I never ‘self-diagnosed’ before then, but I suppose I did not know what I was not seeing.”

Lipset left the nurse’s office with a newfound curiosity about his own biology – how do the variances between people manifest themselves in physical, real-world differences?

Trachoma is the world’s leading infectious cause of blindness. The disease is spread through close personal contact and causes eyelids to turn inward and lashes to scratch the cornea, often leading slowly and painfully to complete loss of sight. It’s a disease that preys on the impoverished – those without enough clean water or decent sanitation – and children are particularly vulnerable to it.

Our Global Health Innovation Grants (GHIG) program is one of the ways we strive to improve access to quality healthcare around the world. The Pfizer Foundation1 partners with nonprofits and social entrepreneurs in developing countries to support innovative health products and services for underserved individuals, and this year’s grants are focused on catalyzing a pipeline of creative ideas in three categories: primary care delivery, women and children’s health, and mobile health technology.

When Suzanne’s husband switched jobs, it changed the family’s insurance situation, and Suzanne knew it could impact their young daughter Savannah’s ability to continue receiving the prescription medicine she needed.

At Pfizer, we believe the cost of prescription medicines should not stand in the way of an individual’s ability to treat his or her health conditions. That’s why for more than 25 years, we have been empowering patients in need with assistance and information so they can get access to the Pfizer medicines prescribed by their doctor.

Miguel Garza is the Chief Financial Officer and Director of New Business Development for Clínicas del Azúcar. Based in Monterrey, Mexico, the clinic’s mission is to provide high-quality low-cost care to prevent and treat diabetes. The organization’s leaders use their background in business to apply entrepreneurial skills to improve the health of people who would otherwise not have access to specialized care.

Stefanie Weiland is the Executive Director of LifeNet International, a franchise health center network with over 85 centers throughout East Africa. They provide training and access to medicines and equipment to improve primary and maternal care for low-income people.

“Our whole mission is to improve the quality of care and the sustainability of these existing healthcare facilities,” explains Stefanie. “These are life-and-death things. It means the difference of a child getting a lethal or a non-lethal dose of medicine.”

Shelley Saxena is the Founder and Chief Executive Officer of Sevamob, which operates 18 mobile clinics in India and South Africa that provide care for more than 20,000 people each month. Shelley is using his entrepreneurial background to redefine expectations about the cost of quality healthcare for low-income patients. Sevamob’s clinics provide critical access to primary and preventive care using a subscription-based model.

Eva Mwai is the Regional Director for East Africa with North Star Alliance, which has built a network of 36 roadside clinics made from refurbished shipping containers throughout 10 countries in Africa. Their clinics provide health services along major transportation routes using scalable and sustainable practices. This unique public-private partnership model provides low-cost primary and sexual healthcare to mobile, at-risk individuals.

Sam Gwer is the Executive Director of Afya Research Africa, which operates a network of clinics in Kenya – Ubuntu-Afya Kiosks – that aim to improve primary care in underserved, rural areas. They currently have 11 clinics in farming and fishing communities, serving 15,000 people.

“We have really empowered communities, and they can see value and the need to participate,” Sam explains. “This is empowering because then with this intervention, we’re able to make an impact on health and wealth.”

Leading up to his first Paralympic Games in Sydney in 2000, Canadian swimming phenom Benoit Huot, then 15, almost didn’t make the trip. With limited support for the Canadian Paralympic Team at the time, the team was short on funds to cover their travel costs to Australia. But just a few months before the Games, Pfizer Canada, which began supporting the Canadian Paralympic Team in 1996, stepped up with a contribution to ensure that athletes and coaches could attend the Games in Sydney.

Marjorie is a practicing physician who also has sickle cell disease (SCD), a lifelong and debilitating genetic disorder that affects red blood cells. She wasn’t diagnosed until she was in her 20s, so for years lived with the daily pain caused by the disease without understanding the cause. Now 43, she credits SCD with making her a better physician. Marjorie says she’s a patient 24 hours a day, which helps her better relate to her own patients.

Pfizer Inc. (NYSE:PFE) and Medivation, Inc. (NASDAQ:MDVN) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion.

World Sickle Cell Day, June 19, 2016, serves as a reminder that more patient volunteers from diverse ethnicities are vitally needed to participate in clinical trials if researchers are to succeed in developing new treatments.

Kyle was an energetic athlete growing up, frequently visiting the high school baseball field to practice hitting and fielding with his father. They both noticed that Kyle’s skills started going downhill, and at age 17, Kyle was diagnosed with Friedreich’s ataxia, a rare progressive neurodegenerative disease that only affects about 5,000 people in the United States.

The story of bringing a medicine to life is no different than any other process of creation. It requires innovation, imagination, and restless perseverance in the face of obstacles both expected and unforseen.

We aim to significantly improve the lives of cancer patients worldwide, with approved therapies for a broad array of cancers. Our robust pipeline of novel medicines will help with our goal to deliver meaningful therapies that transform the cancer treatment landscape.

Science is making breakthroughs in the battle against cancer. On The Doctors, Pfizer Chief Medical Officer Freda Lewis-Hall, M.D., details new advancements in cancer research, including how the body’s immune system can be used to help in the fight.

Pfizer and the Institute of Pediatric Innovation (IPI) issued an open innovation challenge to source ideas for a package and dispensing device that would help administer medicines more easily to children. The winning design team will be announced in August 2016 and awarded a seed grant toward the development of the device. The team will be able to retain all intellectual property related to any inventive aspects of its device.

The broken U.S. tax system puts American companies like Pfizer at a competitive disadvantage.

In the pharmaceutical industry we develop medicines and therapies to address world-wide health challenges. The work is complex and deeply gratifying. At Pfizer we employ more than 30,000 highly skilled people in the United States alone and invest almost $8 billion annually in R&D, much of it in the U.S.

Pfizer Inc. (NYSE: PFE) and Allergan plc (NYSE: AGN) today announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global innovative biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader in a new industry model – Growth Pharma.

This year, the United Nations will adopt 17 Global Goals for a better future. In this inspiring video, Pfizer highlights how everyone can take action to support sustainable development and help build a better world for all.

Content is subject to completion of works council and/or trade union consultations and other legal requirements. Local integration activities may vary by country. Until local integration processes are completed, local Pfizer and Hospira entities will continue operating business as usual, as separate legal entities.

Content is subject to completion of works council and/or trade union consultations and other legal requirements. Local integration activities may vary by country. Until local integration processes are completed, local Pfizer and Hospira entities will continue operating business as usual, as separate legal entities.

Pfizer's "Value of Medicines" papers outline the social health and economic value of a variety of classes of treatments. The supporting 90-second video illustrates the positive impact that medicines have had on a patient, Jack Whelan. Jack faced a life-threatening health condition. His story provides insights into the important role that medicines have played in his journey towards improved health.

Pfizer has long maintained that medicines provide tremendous value to individuals and society as a whole. We have now captured that value in a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas. The data we provide come from published, peer-reviewed studies and are complemented by real stories from patients who have benefited from medicines. We hope these will serve as a resource to those looking to quantify the value of medicines.

Taking care of loved ones as they age is common, but sometimes circumstances force people to become caregivers much sooner than anticipated. On The Dr. Phil Show, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D. visits guest, Stephanie, a 24 year-old young woman who is currently acting as a caregiver for her dad. Visit http://www.gethealthystayhealthy.com/topics/caregiving for caregiving resources.

“The results of PALOMA-3 are compelling and provide evidence that could potentially expand the role of palbociclib as an innovative first-in-class therapy for women with HR+, HER2- metastatic breast cancer whose disease has progressed despite prior hormonal therapy.”

"Immuno-oncology will play an important role in the future of cancer treatment. At Pfizer, we are dedicated to pushing the science of IO further. We have an IO strategy that enables us to rapidly identify and evaluate the most promising strategies for the most patients."

“At ASCO, we’re proud to showcase new, robust data on medicines with the potential to impact patients worldwide. Metastatic breast cancer is an example of where we have brought innovative, breakthrough science to target a particularly difficult-to-treat disease.”

“Advances in cancer treatment are occurring at a remarkable pace. Pfizer is at the forefront of discovery and development of multiple cutting-edge cancer medicines and has achieved this by putting patients at the center of everything we do.”

“The results of PALOMA-3 are compelling and provide evidence that could potentially expand the role of palbociclib as an innovative first-in-class therapy for women with HR+, HER2- metastatic breast cancer whose disease has progressed despite prior hormonal therapy.”

“The ultimate mission of Pfizer Oncology is to cure patients living with cancer. We are working toward this goal and have launched four new products in the last five years. This year’s ASCO showcases our commitment to discovering breakthrough medicines representing true progress for patients.”

Fibromyalgia is a chronic disorder, characterized by widespread pain and tenderness, that may affect more than five million US adults. On The Doctors, Chief Medical Officer Freda Lewis-Hall, M.D. discusses this complex, misunderstood condition and steps to help manage it. Visit http://www.gethealthystayhealthy.com to learn more.

Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., discusses the importance of adult vaccination and why it is important to talk to a healthcare provider about appropriate vaccines that may protect you or a family member.

We seek to bring more medicines to more people and to improve health around the world. Our social investments focus on effective and sustainable health care delivery for underserved patients, wherever they live, while empowering our colleagues, strengthening our stakeholder relationships and ultimately having a positive impact on society and our business.

Just as science has advanced tremendously over the last decade, so has our understanding of how we need to collaborate to advance innovation more quickly and effectively. Our creative approach to external collaboration has resulted in new types of arrangements with government, academia, patient advocacy groups and the biomedical industry.

Cigarette smoking contributes to about 1 of every 5 deaths in the U.S. each year and nearly 9 in 10 smokers first tried cigarettes by age 18. On The Dr. Phil Show, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., and Dr. Phil talk with guest, Traci, who started smoking at age 14, and discuss Traci’s concerns that her teenage son will also start smoking. Visit http://www.gethealthystayhealthy.com to learn more.

Millions of Americans have cholesterol counts high enough to increase their risk of heart disease or stroke. High cholesterol can be caused by many factors – it can even be inherited. Pfizer’s Chief Medical Officer Freda Lewis-Hall, M.D., joined by Katherine Wilemon, President of The FH Foundation, visit TheDoctors to discuss cholesterol and why it’s important to know your levels and risk factors – and to take steps to manage them. Visit http://www.gethealthystayhealthy.com to learn more.

Long flight ahead? Sitting all day at the office? You may be at risk for developing a blood clot in your veins. On The Doctors, Pfizer’s Chief Medical Officer Freda Lewis-Hall, M.D. details the risk factors and talks tips to help prevent blood clots. Visit http://www.gethealthystayhealthy.com to learn more.

Pfizer Inc. (NYSE: PFE) and Hospira, Inc. (NYSE: HSP) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world's leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 a share in cash for a total enterprise value of approximately $17 billion.

“This approval represents the first treatment advance for this group of women in more than 10 years. It’s exciting to think about the potential of this new medicine to help so many patients with advanced disease.”

“With the approval of IBRANCE, scientists and clinicians at Pfizer have demonstrated an unwavering commitment to improving the care of patients with breast cancer. This breakthrough therapy is another example of Pfizer's commitment to the discovery and development of innovative medicines.”

“This approval is a major step forward for patients and for Pfizer as it signifies the strength of our science. We have the opportunity to positively impact lives by providing a new treatment option to postmenopausal women with ER+/HER2- advanced breast cancer.”

Think measles, whooping cough, or polio are diseases of the past? Think again. When vaccination rates drop, some potentially deadly diseases can come back from near-extinction. On The Doctors, Pfizer's Chief Medical Officer Freda Lewis-Hall and the show's host, Travis Stork, explain how vaccines help protect not only individuals but also their families and communities, and stress the need for continued vigilance against dangerous but preventable diseases. Visit http://www.gethealthystayhealthy.com to learn more.

Glaucoma can lead to blindness, but it doesn’t have to. Early diagnosis may help to save your sight. On The Doctors, Pfizer‘s Chief Medical Officer Freda Lewis-Hall, M.D. takes a trip to the eye doctor for a glaucoma test. Visit http://www.gethealthystayhealthy.com to learn more.

Inflammatory Bowel Disease (IBD), which includes Ulcerative Colitis and Crohn’s Disease, is estimated to affect more than 1 million people in the U.S., but is widely misunderstood. On The Dr. Phil Show, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., and Dr. Phil sit down with guest Diane, who suffers from Ulcerative Colitis, to discuss the serious physical and emotional toll of IBD and address the misinformation surrounding it. Visit http://www.gethealthystayhealthy.com to learn more.

Meningococcal disease, spread by typical adolescent and young adult behaviors such as close quartered living, sharing utensils and kissing, is often mistaken early on for the flu, and can turn deadly within 24 hours.

On Inside Edition, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., talks to Deborah Norville about why keeping current on vaccinations is the right thing to do for individuals and families – and for public health.

Pfizer is a global leader in providing information regarding the dangers of counterfeit medicines, and has joined with other pharmaceutical companies to seek solutions to the problem of fake medicines through the Pharma Security Institute, a consortium founded by 14 leading pharmaceutical companies, among other efforts.

World Pneumonia Day is November 12. Pneumonia, including pneumococcal pneumonia, is a leading cause of illness and death that affects people of all ages worldwide. It’s important to know your risk. Watch now and share to get the word out.

Traveling can be stressful, especially around the holidays, and no one wants a medical mishap to keep them from enjoying their destination.On The Doctors, Pfizer's Chief Medical Officer, Freda Lewis-Hall, M.D. opens her suitcase and shares travel tips and packing essentials you should never leave home without. Visit http://www.gethealthystayhealthy.com to learn more and for a quick trick on how to stay C.A.L.M and remember these travel tips.

In drug development, Pfizer is continuously advancing new technology platforms and innovating with groundbreaking collaborations to bring safe and effective medicines to patients.A critical step in that process is making clinical trials more transparent and providing healthcare professionals and researchers with the right tools to support the delivery of high quality trials. Drawing on experienced investigators knowledge and feedback, Pfizer's Clinical Trial Support and Compliance organization recently launched INVESTIGATE, an informative platform that provides an interface between external investigator sites and Pfizer.

Counterfeit drugs are health hazards and are hard to spot without testing in a lab. They often lack active pharmaceutical ingredients and may even contain harmful ingredients, like lead paint and poison. On The Doctors, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., and Global Security Officer John Clark uncover counterfeit drug operations, the risks they pose to patients, and tips to protect yourself when buying prescriptions online. Visit http://www.gethealthystayhealthy.com to learn more.

Pfizer's purpose is to innovate to bring therapies that significantly improve patients' lives. R&D is at the heart of fulfilling Pfizer's purpose as we work to translate advanced science and technologies into the therapies that matter most.

Every day, an estimated 6,000 women in the United States reach menopause and may experience related symptoms like hot flashes, night sweats, mood swings, among many others. On The Dr. Phil Show, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D., and Dr. Phil meet Jeannie and her husband, Joe, and discuss steps women can take to tackle menopause symptoms and how partners can offer support. Visit http://www.gethealthystayhealthy.com to learn more.

Considering the high degree of unmet need in metastatic breast cancer, the ongoing research for innovative treatments represents hope for many patients, their clinicians, and all those affected by this disease.

During Breast Cancer Awareness Month, most of the breast cancer conversation centers around early detection and survivorship. As inspiring and important as that effort is, there’s strikingly little knowledge among the public about metastatic breast cancer. Up to a quarter of a million people are living with this diagnosis today in the U.S., but in a recent survey, more than 60 percent of people said they know little to nothing about it.

The international weekly science journal Nature recently published findings from a large, multi-country study identifying 108 genes, 83 of these unknown before, as contributing to schizophrenia risk. These findings more than triple the number of genetic associations previously known for this disease. Pfizer, through an agreement with the Broad Institute, contributed samples to the investigation, which was conducted by the Psychiatric Genomics Consortium (PGC), a collaboration of more than 80 institutions that analyzed data for more than 150,000 adult subjects.

It’s perfectly natural to have a FOGO (Fear of Getting Old), but there’s also a solution: healthy living. On The Dr. Phil Show, Freda Lewis-Hall, M.D. and Dr. Phil talk to Randi, whose FOGO has her dreading a future of wrinkled skin, granny dresses and rocking chairs. Check your local listings to watch the show and visit ‪‬‬‬‬‬‬www.GetOld.com to learn more.‬‬

The Pfizer Foundation has announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa, focusing on ‘last-mile’ interventions to reach underserved populations living in Ethiopia, Malawi, Rwanda, Uganda and Zambia. Grant recipients include UNICEF, Save the Children and International Rescue Committee.

Bacterial meningitis is an uncommon, but serious disease, and many students and parents have questions about what to know in order to help protect themselves and their loved ones as they head back to school.

On The Doctors, Pfizer’s Chief Medical Officer, Freda Lewis-Hall, M.D. shares critical information regarding the disease and tips for teens and young adults to help identify and change behaviors that can lead to the spread of bacteria that can cause meningitis. Visit http://www.gethealthystayhealthy.com to learn more.

The results of this year’s Pfizer Healthcare Ireland (PFI) Index, announced at the Royal College of Physicians of Ireland in Dublin, reveal the impact that years of recession and austerity budgets have had on people, and shows a broad consensus that cuts in healthcare have had the greatest impact when contrasted with cuts in social welfare, education, state pension and transport.

Pfizer China donated one million RMB to the Red Cross Society of China for rescue and relief operations and worked with local healthcare and medical institutions in following a magnitude 6.5 earthquake in Ludian, Yunnan, a province in Western China.

The use of statins correlates to a 27-percent savings in health care costs per patient. View a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas.

Psoriasis is a chronic immune mediated inflammatory disorder that affects approximately 7 million Americans. On The Dr. Phil Show, Freda Lewis-Hall, M.D. and Dr. Phil talk to Seger, an individual living with psoriasis whose co-workers believed her condition was contagious. Check your local listings to watch the show and visit http://www.gethealthystayhealthy.com to learn more.

The Global Health Fellows Program (GHF) is an international corporate volunteer program that places Pfizer colleagues and teams in short term assignments with leading international development organizations in key emerging markets. Global Health Fellow Nivi Nehra recently traveled to Gowa, Indonesia, to work with RTI International’s Expanding Maternal and Newborn Survival (EMAS) initiative.

Pfizer and a number of its industry peers, including Janssen Research & Development, L.L.C. and Sanofi, have committed 26 new agents to The National Institutes of Health (NIH) and its National Center for Advancing Translational Sciences (NCATS) to expand its Discovering New Therapeutic Uses for Existing Molecules program.

Asking someone with dementia to stop driving is a big decision. But for a number of reasons, especially safety, it’s sometimes necessary. On the Dr. Phil Show, Freda Lewis-Hall, M.D. and Dr. Phil discuss the issue. Check your local listings to watch the show and visit http://www.gethealthystayhealthy.com to learn more.

Today marks the 70th anniversary of D-Day. Pfizer pioneered the process of deep-tank fermentation, which allowed the company to mass-produce the life-saving antibiotic penicillin Allied troops took ashore with them on June 6, 1944. For this innovation, Pfizer earned the Army-Navy “E” Award for excellence in war production.

Smoking is not just a bad habit - it is an addiction. On Dr. Phil Show, Freda Lewis-Hall, M.D. and Dr. Phil talk to Loree, a nurse who started smoking at the age of 12, about not giving up and working with a doctor to quit. Check your local listings to watch the show and visit http://www.gethealthystayhealthy.com to learn more.

MRSA is a drug-resistant staph bacterium that has become a problem not just in hospitals but in common places such as schools, gyms and locker rooms. On The Doctors, Freda Lewis-Hall, M.D. and Dr. Travis Stork discuss this often very serious infection and steps you can take to help reduce risk to you and others. Check your local listings to watch the show and visit http://www.gethealthystayhealthy.com to learn more.

On World Hemophilia Day (April 17), Pfizer’s Freda Lewis-Hall, MD and Dr. Travis Stork from The Doctors sat down with actress, writer, and comedian Alex Borstein to talk about her family’s experiences of living with hemophilia, a rare bleeding disorder in which the blood does not clot normally. Check your local listings to watch the show and visit http://www.gethealthystayhealthy.com to learn more.

Through the Influencers program, LinkedIn publishes insights from leaders from around the world covering a variety of fields on topics ranging from leadership and management to careers to "what inspires me." Ian is one of the first pharmaceutical company CEOs to join.

On Feb 28, Pfizer proudly joins the European Organization for Rare Diseases (EURORDIS), the National Organization for Rare Disorders (NORD), as well as a coalition of patient organizations, professional societies, government agencies, researchers and biopharmaceutical companies supporting the urgent need to raise awareness of rare diseases and their impact on patients across the globe.

The Pfizer Foundation recently made a $5 million investment in a first-of-its-kind fund that will finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

Former U.S. President Jimmy Carter recently joined Pfizer to commemorate the 15th Anniversary of the International Trachoma Initiative (ITI), an independent, not-for-profit program dedicated to the elimination of blinding trachoma as a public health concern.

In a survey that asked more than 64,500 students from more than 100 top universities in China which organizations they would most want to work for after graduation, Pfizer ranked “most attractive” in the health and medicine category.

Pfizer has launched a new initiative called Making Moments — available at www.ADHDMoments.com — which aims to help provide families with resources to address Attention Deficit Hyperactively Disorder (ADHD).

Pfizer Animal Health and The Hippolia Foundation — a network of leading French equine institutions — have formed a strategic partnership to advance equine health through research and educational programs.

With the growing availability of electric-powered vehicles and hybrids, Pfizer is doing its part to ensure that colleagues at the company's facility in Groton, Connecticut are plugged into the latest electric car developments.

Pfizer's Janet White, who is currently working on assignment in Uganda as part of the company's Global Health Fellows program, recently reunited with a man she once sponsored through World Vision when he was a child.

The Pfizer Foundation is partnering with Grantmakers in Aging, a national association of funders, to launch "Community AGEnda: Improving America for All Ages," to help five U.S. communities become great places to grow up and grow old.

In recognition of World AIDS Day, which occurred on Dec. 1, Pfizer recently hosted a display of sections of the internationally celebrated AIDS Memorial Quilt, the 54-ton, handmade tapestry that stands as a memorial to more than 94,000 individuals lost to AIDS.

Pfizer 'Leans In' to Celebrate Women's History Month

Pfizer has joined a new online community that aims to help women achieve professional goals.

As part of its commemoration of Women's History Month in March, Pfizer has joined a global community committed to encouraging and supporting women to help them achieve their goals. The community, called Lean In, was launched in 2011 by Facebook Chief Operating Officer Sheryl Sandberg and takes advantage of the Web and social media to offer materials and programs, such as:

Pfizer Global Supply (PGS) is installing a wind turbine at it's facility in Puurs that will serve as an alternative energy source that will reduce consumption, lower emissions and save the company over $1 Million annually.

Every Wednesday throughout the summer, a program hosted by Pfizer turns Puerto Rico's Museum of Art in San Juan into the backdrop for an afternoon of learning about a particular Caribbean island for hundreds of underprivileged children.

A local nursing student and first-time recipient of a unique Pfizer scholarship is raising awareness about patients who are struggling to receive health care by writing about her experience this summer at a community health care center in Kalamazoo, Mich.

Colleagues at the Pfizerýýýs Global Supply plant in Sanford, N.C., recently turned into a barber shop as a team of 14 people had their heads shaved in front of their peers to raise money for childhood cancer.

Pfizer recently launched a new speaking book, Safe Use of Medicines, in Kampala, Uganda, and in a rural village outside of Dakar, Senegal, to encourage the safe and appropriate use of medicines, regardless of the user's level of education and literacy.

As part of a Pfizer-sponsored awareness campaign, two hundred performers recently created a giant human hand in London's Covent Garden to visually illustrate a symptom of Dupuytren's disease, a progressive and debilitating hand condition.

Pro bono laboratory work being conducted for Mystic Aquarium in Connecticut by Pfizer scientists is contributing to the well-being of all manner of aquatic life at the institution, from sea turtles and African penguins to Steller sea lions and beluga whales.

Pfizer Pfizer colleagues in the U.S. recently raised more than $50,000 by wearing jeans to work in return for a minimum $5 charitable donation to LIVESTRONG, the cancer survivorship organization founded by Lance Armstrong.

Although heart disease is the leading cause of death among women in Singapore, a recent poll conducted by Pfizer Singapore revealed that only 20 percent of respondents ranked heart disease as their greatest health concern.

Pfizer Brazil colleagues recently participated in the second annual Pfizer Volunteers Day, spending their workday with low-income senior citizens and children in local communities near the company's São Paulo offices.

Feb. 29 is Rare Disease Day, and Pfizer is joining with the National Organization for Rare Disorders and a variety of other organizations to create awareness of rare diseases and their impact on patients.

A national platform for genetic cancer diagnostics, initiated by Pfizer's Oncology Business Unit in Norway, is helping to ensure that patients receive fast and accurate diagnoses and access to treatments.

Michael Ehlers, Chief Scientific Officer of Pfizer's Neuroscience Research Unit, will be awarded the prestigious Thudichum Medal by the Biochemical Society, the U.K.'s largest discipline-based professional and academic society in the biosciences.

The Virginia Department of Game and Inland Fisheries (DGIF) recently recognized Pfizer's Richmond Sherwood Consumer Healthcare Research and Development site for its contributions to DGIF's Corporate Habitat Program.

Pfizer Nigeria, in collaboration with the Ophthalmological Society of Nigeria, has established the Glaucoma Patients Association for Lagos State, Nigeria, to encourage the prevention and treatment of glaucoma by supporting early detection of the disease.

Pfizer is partnering in a National Institutes of Health collaborative program that will match academic researchers with dozens of pharmaceutical industry-owned molecules to help scientists explore new treatments for patients. (Photo credit: NIH, Ernie Branson)

Pfizer colleague David Cox is one of several leading scientists featured in Life Sciences Foundation's virtual oral history initiative designed to promote the organization's mission — to record, preserve and promote the story of biotechnology.

The historic Auzoux Horse, one of the first veterinary teaching aids of its kind, has been restored to its original condition in France thanks to a €50,000 (approximately USD 65,698) grant from Pfizer Animal Health.

Pfizer's Deanna Angello would accept almost any challenge to raise awareness and funds to find effective treatments for frontotemporal dementia, an aggressive form of dementia that affects middle-aged people.

A new agreement between Pfizer Colombia and a local nonprofit organization, Fundación Héroe Camina — or the Hero Walking Foundation — will provide academic scholarships to 52 Colombian National Army soldiers who are disabled due to landmine and improvised explosive device injuries.

Four years after a tragic, life-threatening motorcycle accident that resulted in the loss of his leg, Pfizer Greece colleague Pangiotis Saoulidis has taken home a gold medal in the National Championship of the Pan-Hellenic Sports Federation for Persons with Disabilities.

Colleagues from Pfizer Nutrition in Hong Kong recently joined more than 50 adults and children from a local food bank in making healthy, nutritious rice dumplings during the country's annual Dragon Boat Festival celebrations.

Pfizer's Charles Mitchell and his 9-year-old daughter, Taylor, were among 19 colleagues and family members who recently shaved their heads in support of the "Shaving the Way to Conquer Kids' Cancer" fund-raiser for St. Baldrick's Foundation.

The Pfizer Thailand Foundation is offering scholarships for pediatricians in the Lao People's Democratic Republic, also known as Laos, to attend a three-year training program in hemato-oncology, as well as infectious diseases in children, at the Faculty of Medicine, Khon Kaen University, Thailand.

Katie Taylor, Ireland's Olympic Gold Medal winner in boxing, recently lent her support to the launch of Healthy Towns, a new initiative sponsored by Pfizer Ireland and The Irish Times that aims to increase the health and wellness of an entire town or city.

Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, used Pfizer Consumer Healthcare's Centrum Silver for the Physicians' Health Study II, a 12-year study conducted by the hospital that tested the role of multivitamins in relation to long-term health benefits in men 50 and older.

Pfizer Ireland's recently published 2012 Pfizer Health Index, an annual quantitative market research survey of the health and well-being of the Irish population, offers an in-depth look into the lives of elderly patients.

Two recent collaborations demonstrate Pfizer's commitment to working with external partners to broaden its scientific expertise and accelerate the translation of science into treatments that can help patients.

Two has become the first biopharmaceutical company in Ireland to be awarded the prestigious Business Working Responsibly Mark, which certifies excellence in responsible and sustainable business practices.

The Bonnie J. Addario Lung Cancer Foundation recently honored Pfizer with the Dr. Fred Marcus "Simply the Best" Award for the development of Lung Cancer PROFILES, an educational campaign for consumers and health care professionals that aims to decrease the stigma of lung cancer and increase awareness of the importance of diagnostic testing.

Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.